Form D · Biotechnology
Allele Biotechnology & Pharmaceuticals, Inc.
San Diego, CA · CIK 0001617865
Offering snapshot reported Oct 26, 2016 · SEC filing
- Reported sold
- $11M Offering amount: $11M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 11, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2016 | Initial | $11,000,000 | No comparison | 4 | SEC filing |
| Sep 12, 2014 | Initial | $7,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-273224
Source: Form D, filed Oct 26, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Quishi Fu | Director |
| Robert La Polla | Director |
| Shao Chung Tsai | Director |
| Jiwu Wang | Director, Executive |
| Lin Yang | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6404 Nancy Ridge Drive
San Diego, CA, 92121
San Diego, CA, 92121